Genmab A GMAB
NASDAQ GMAB
$40.00 +0.43 (+1.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genmab A (GMAB) Net Shares Issued and Repurchased (2023 - 2026)

Updated

Analysis

Genmab A (GMAB) Net Shares Issued and Repurchased (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -966.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -9.00 Mn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 6.00 Mn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Genmab A 2.58 Bn -2.80 Bn 1.07 Bn -191.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -191.00 Mn
Mar 31, 2026 98.00 Mn
Mar 31, 2025 1.00 Mn
Mar 31, 2024 88.00 Mn
Dec 31, 2023 -767.00 Mn
Mar 31, 2023 575.00 Mn
API Access

Genmab A Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=GMAB&period=max&api_key=YOUR_API_KEY